NR4A2 haploinsufficiency is associated with intellectual disability and autism spectrum disorder.
Jonathan LévyS GrottoC MignotA MaruaniA Delahaye-DuriezB BenzackenB KerenD HayeJ XavierM HeulinE CharlesAlain VerloesC DupontE PipirasAnne-Claude TabetPublished in: Clinical genetics (2019)
NR4A2, a member of the nuclear receptor superfamily, is involved in modulation of target gene transcription, regulating several developmental processes such as regulation of cellular homeostasis, neuronal development, inflammation and carcinogenesis. 2q24.1 deletions are extremely rare, and only 1 patient with a de novo deletion encompassing only NR4A2 gene was reported so far. We report 3 additional patients with a de novo deletion encompassing NR4A2: 2 patients have deletions encompassing only NR4A2 gene and 1 patient has a deletion including NR4A2 and the first exon of GPD2. Our patients presented a neurodevelopmental disorder including language impairment, developmental delay, intellectual disability and/or autism spectrum disorder. We suggest that NR4A2 haploinsufficiency is implicated in neurodevelopmental disorder with high penetrance.
Keyphrases
- intellectual disability
- autism spectrum disorder
- end stage renal disease
- attention deficit hyperactivity disorder
- ejection fraction
- newly diagnosed
- chronic kidney disease
- copy number
- prognostic factors
- peritoneal dialysis
- genome wide
- case report
- transcription factor
- genome wide identification
- blood brain barrier
- genome wide analysis